The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Arnab Chakravarti

Massachusetts General Hospital/Harvard Medical School

Department of Radiation Oncology


MA 02114



Name/email consistency: high



  • Massachusetts General Hospital/Harvard Medical School, Department of Radiation Oncology, Boston, MA 02114, USA. 1999 - 2007
  • Radiation Therapy Oncology Group Genitourinary Translational Research Program. 2003


  1. Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202. Chakravarti, A., DeSilvio, M., Zhang, M., Grignon, D., Rosenthal, S., Asbell, S.O., Hanks, G., Sandler, H.M., Khor, L.Y., Pollack, A., Shipley, W. J. Clin. Oncol. (2007) [Pubmed]
  2. Impact of molecular profiling on clinical trial design for glioblastoma. Chakravarti, A., Tyndall, E., Palanichamy, K., Mehta, M., Aldape, K., Loeffler, J. Curr. Oncol. Rep (2007) [Pubmed]
  3. Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms. Chakravarti, A., Erkkinen, M.G., Nestler, U., Stupp, R., Mehta, M., Aldape, K., Gilbert, M.R., Black, P.M., Loeffler, J.S. Clin. Cancer Res. (2006) [Pubmed]
  4. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group. Chakravarti, A., Winter, K., Wu, C.L., Kaufman, D., Hammond, E., Parliament, M., Tester, W., Hagan, M., Grignon, D., Heney, N., Pollack, A., Sandler, H., Shipley, W. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  5. Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group. Chakravarti, A., Seiferheld, W., Tu, X., Wang, H., Zhang, H.Z., Ang, K.K., Hammond, E., Curran, W., Mehta, M. Int. J. Radiat. Oncol. Biol. Phys. (2005) [Pubmed]
  6. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. Chakravarti, A., Dicker, A., Mehta, M. Int. J. Radiat. Oncol. Biol. Phys. (2004) [Pubmed]
  7. The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. Chakravarti, A., Zhai, G., Suzuki, Y., Sarkesh, S., Black, P.M., Muzikansky, A., Loeffler, J.S. J. Clin. Oncol. (2004) [Pubmed]
  8. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Chakravarti, A., Zhai, G.G., Zhang, M., Malhotra, R., Latham, D.E., Delaney, M.A., Robe, P., Nestler, U., Song, Q., Loeffler, J. Oncogene (2004) [Pubmed]
  9. Molecular and genetic prognostic factors of prostate cancer. Chakravarti, A., Zhai, G.G. World. J. Urol (2003) [Pubmed]
  10. Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10. Chakravarti, A., Heydon, K., Wu, C.L., Hammond, E., Pollack, A., Roach, M., Wolkov, H., Okunieff, P., Cox, J., Fontanesi, J., Abrams, R., Pilepich, M., Shipley, W. J. Clin. Oncol. (2003) [Pubmed]
  11. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling. Chakravarti, A., Loeffler, J.S., Dyson, N.J. Cancer Res. (2002) [Pubmed]
  12. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. Chakravarti, A., Noll, E., Black, P.M., Finkelstein, D.F., Finkelstein, D.M., Dyson, N.J., Loeffler, J.S. J. Clin. Oncol. (2002) [Pubmed]
  13. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner. Chakravarti, A., Chakladar, A., Delaney, M.A., Latham, D.E., Loeffler, J.S. Cancer Res. (2002) [Pubmed]
  14. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Chakravarti, A., Delaney, M.A., Noll, E., Black, P.M., Loeffler, J.S., Muzikansky, A., Dyson, N.J. Clin. Cancer Res. (2001) [Pubmed]
  15. Megavoltage radiation therapy for axial and inoperable giant-cell tumor of bone. Chakravarti, A., Spiro, I.J., Hug, E.B., Mankin, H.J., Efird, J.T., Suit, H.D. J. Bone. Joint. Surg. Am (1999) [Pubmed]
WikiGenes - Universities